Taurine Market Projected to Grow at 7.2% CAGR from 2023 to 2033, Industry Data Shows

Picture background

The taurine market is anticipated to be worth USD 415.0 million in 2023 and USD 815.4 million by 2033. During the projection period, taurine sales are anticipated to experience a strong CAGR of 7.2%.

Taurine, known as the wonder molecule, is increasingly being used in products such as energy drinks, dietary supplements, and others. It has made a name for itself in the global market due to its use on both animals and humans.

Energy drinks are becoming increasingly popular around the world. Taurine is found in energy drinks and is used to increase physical activity and bodybuilding. Red Bull is a well-known energy drink containing Taurine. It is widespread in both developed and developing countries.

Growth in international sporting events has compelled sportsmen to concentrate on preserving their physical fitness, which is anticipated to spur growth in the approaching years.

However, excessive use of taurine as a supplement can cause health problems, limiting the taurine market’s growth. Increased research and development and new product launches are expected to drive the taurine market forward in the near future.

Key Takeaways from the Taurine Market

  • The taurine market in the United States is expanding at a rate of 6.9% as a result of important product launches, increased research activity, and a high concentration of manufacturers or market players, in the country.
  • With a revenue share of US$ 40 million, the United Kingdom has contributed a sizeable share of the global market. The growing online sales channel and expansion of sports nutrition are proliferating market growth.
  • Food-grade taurine tops the segment showcasing a growth of 5.6%. Taurine in food acts as an emulsifier and flavor enhancer in processed foods. Taurine is widely used in the production of packaged cereal, baby products, bakery items, and other items due to its properties. The growing demand for processed and packaged foods is driving up global demand for taurine.
  • Currently, China holds a commanding growth rate of 7.9% in the Asia Pacific region. China is a leading producer of taurine, with more than 40 manufacturers in the country contributing to the world’s prominent production of the market product. Several manufacturers are outsourcing Taurine production to China and looking for low-cost suppliers in this country.
  • Due to rising public awareness of fitness and well-being, the dietary supplements industry is expected to develop at the strongest pace of 11.5%. An increase in sporting events and activities is likely to expand market reach.

Competitive Landscape

Companies in the taurine market are attempting to increase taurine production capacity. Companies such as Qianjiang Yongan Pharmaceutical Co., Ltd. have an annual production capacity of 58,000 MT of taurine and are planning to expand production and storage capacity. Concurrently, the company is strengthening its supply chain to support this increase in volume.

Latest Developments

  • Manufacturers including Qianjiang Yongan Pharmaceutical Co., Ltd., Songzhou Hu, and Vitaworks Ip, Llc are working on a novel taurine production process for the global market. Manufacturers strive to develop sustainable production processes, use less raw materials, and waste less. Manufacturers such as Kyowa Hakko Bio Co., Ltd. have developed a fermentation-based taurine production process because it creates a more controlled environment for several production factors and taurine extraction.
  • Mimi’s Rock Corp. announced in February 2022 that its supplements brand, Dr. Tobias, is extending the range of products it offers by adding digestive enzymes, prebiotics, and probiotics to support gut health.

Access the full report for detailed market trends. https://www.futuremarketinsights.com/reports/taurine-market

Key Segments Covered in the Taurine Market Report

By Grade:

  • Food Grade
  • Feed Grade
  • Pharmaceuticals Grade
  • Others

End-use Application:

  • Food
    • Dairy Products
    • Infant
    • Bakery Products
    • Cereal Products
  • Beverage
    • Energy Drinks
    • Caffeinated Drinks
    • Soft & Carbonated Drinks
  • Animal Feed
    • Aquaculture Feed
    • Poultry Feed
  • Pet Food
    • Cat Food
    • Dog Food
  • Pet Supplements
    • Cat Supplements
    • Dog Supplements
  • Dietary Supplements
  • Cosmetics & Personal Care
    • Skin Care Products
    • Hair Care Products
    • Toiletries
  • Agriculture
  • Pharmaceuticals

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Food Acidulants Market Growth Opportunities and Trends Forecast to 2033

Food Acidulants Market
Food Acidulants Market

The food acidulants market is valued at US$ 2.6 billion in 2023 and is estimated to reach a value of US$ 4.5 billion by 2033, registering a CAGR of 5.4% during the forecast period.

The rising disposable income and growing demand for clean-label products and processed food are increasing the market share. Furthermore, the demand for food acidulants is fueled by the growing food industry, government initiative plans and emerging economies. In addition, the food and beverage manufacturers are fueling the market size by increasing the production of food acidulants during the forecast period.

One of the major factors helping to boost the food acidulants market size is the growing demand for healthy nutrition, citric beverage and preserved food among consumers. Moreover, the growing adoption of food acidulants by manufacturers is enhancing the taste of jellies, jams, cakes and pastries.

Adopting fumaric acid in several beverages to provide acidic flavor surges with the global market expansion.

Increasing demand for beverages among consumers all around the region is contributing to maximum revenue. Hence, the manufacturers are introducing several unique products to attract consumers and are increasing market trends during the forecast period. Moreover, the adoption of citric acid for desserts, syrups and exotic beverages is enhancing the market share. An increase in the trends of ready-to-eat food leads to the growing demand for food acidulants in the food sector.

The bakery and confectionery records a CAGR of 5.2% in the food acidulants market. The growing demand for cakes and pastries among children increases the demand for bakery and confectionery. Increasing demand for packed food and enhanced food shelf life drives the market expansion.

Powder Category is the most Sought-after in Foam Segment

The powder category leads the food acidulants market by occupying a CAGR of 5.6% during the forecast period. There is a growing demand for powder foam due to its better storage, ease of use and transport. The increasing consumer preferences are bolstering the demand for powder-form food acidulants.

Growing demand for nutritional diets for animals results in the increasing adoption of powder foam. The powder foam recorded a CAGR of 4.3% in its historical period from 2017 to 2022.

Key Takeaways:

  • The food acidulants marketvaluation is expected at US$ 4.5 Bn by 2033.
  • The global market is likely to increase during the forecast period witnessing a CAGR of 5.4%.
  • The market in the United States is anticipated to grow at a CAGR of 3.8% through 2033.
  • With a CAGR of 6.0%, the Indian market will significantly uplif during the forecast period.
  • The UK market is expected to grow at a CAGR of 4.5% over the forecast period.

Who is winning?

The market is growing at a moderate pace due to the number of prominent leaders in the global market. The growing local and international companies are advancing the business with the global players. These players are strengthening their companies through unique and innovative product launches.

The growing technological advancement, research activities and adopting market strategies by prominent players are the major factors anticipated to fuel the market expansion during the forecast period.

In 2021, a US-based Company, KPS Capital Partners, acquired Tate & Lyle to expand their business in North America and Latin America.

Food Acidulants Market by Category

By Type:

  • Acetic Acid
  • Fumaric Acid
  • Citric Acid
  • Phosphoric Acid
  • Lactic Acid
  • Malic Acid
  • Tartaric Acid

By Foam:

  • Liquid
  • Powder

By Function:

  • Flavor Enhancer
  • Microbial Control
  • pH Control
  • Preservative
  • Others

By Application:

  • Bakery and Confectionery
  • Beverages
  • Dairy Food
  • Animal Nutrition

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Vegan Protein Powder Market Outlook: A Comprehensive Analysis to 2033

Vegan Protein Powder Market
Vegan Protein Powder Market

According to Future Market Insight, the Global Vegan Protein Powder Market will reach US$ 9.07 billion by 2033, registering a CAGR of 7.4%. This anticipated growth signifies a remarkable upsurge from its projected worth of US$ 4.63 billion in 2023.

There has been a significant increase in people adopting vegan and vegetarian diets worldwide. Ethical considerations, environmental concerns, and personal health benefits motivate individuals to embrace plant-based lifestyles. As a result, the demand for plant-based protein powders has skyrocketed. Plant-based protein powders offer a convenient and accessible source of Protein without relying on animal-derived ingredients.

The increasing desire for protein supplements to enhance well-being and promote good health greatly contributes to expanding the vegan protein supplement market. The fast-paced nature of modern lifestyles and busy schedules have led to a higher demand for convenient protein sources. Moreover, vegan protein powders offer a suitable alternative for individuals who are lactose intolerant or have other dietary restrictions.

Given their high amino acid content, protein powder supplements are also gaining popularity among fitness enthusiasts seeking muscle development. Vegan protein powders have recently gained considerable popularity among athletes and fitness enthusiasts. These powders are derived from plant-based sources such as peas, rice, hemp, soy, and other legumes. They offer a convenient and effective way to increase protein intake, which is crucial for muscle repair and growth.

The increasing popularity of plant-based milk alternatives has significantly contributed to the rising demand for vegan protein powders. Soy milk, almond milk, and pea milk are widely consumed as substitutes for dairy milk and have gained popularity. Plant-based milk alternatives are often perceived as healthier than dairy milk due to their lower saturated fat content and potential health benefits associated with the plant-based ingredients.

Soy protein isolate is a high-quality, easily digestible protein with a neutral flavor. Pea protein powders are another good source of plant-based Protein. They don’t contain gluten and have minimal carbs. These factors make these alternative protein powders a popular choice among vegan consumers.

Vegan protein powders have expanded their reach through various distribution channels. They are readily available in health food stores, supermarkets, online platforms, and specialized vegan stores. E-commerce has created opportunities for established brands and emerging start-ups to reach a wider customer base. Online platforms offer convenient access to a variety of vegan protein powders, facilitating ease of purchase for consumers. This increased accessibility has significantly boosted the Market. It has made vegan protein powders easily accessible to a wider range of consumers.

The vegan protein powder market has seen successful marketing campaigns and endorsements by influential individuals. Celebrities, athletes, and fitness influencers have endorsed vegan protein powders. These endorsements have raised awareness and highlighted the benefits of vegan protein powders. They have managed to attract the interest of a broader range of viewers. Marketing efforts have played a pivotal role in promoting the growth of the vegan protein powder market.

Manufacturers continuously innovate to improve vegan protein powders’ taste, texture, and nutritional profiles. They are also introducing new flavors and incorporating additional functional ingredients, such as probiotics and superfoods, to enhance the overall health benefits.

In response to the growing demand for personalized nutrition, certain companies in the vegan protein powder market have started offering products tailored to the individual’s specific needs. This personalization considers factors such as age, gender, and fitness goals to provide a more customized and targeted protein supplement.

Key Takeaways from the Vegan Protein Powder Market

  • The United States held a 17.2% share of the global vegan protein powder industry in 2022.
  • India is expected to have strong growth in the vegan protein powder industry, with a CAGR of 4.7% during the projected period.
  • In 2022, Japan had a 4.8% share of the vegan protein powder industry globally.
  • China’s vegan protein powder industry is expected to flourish speedily, registering a CAGR of 10.2% over the forecast period.
  • Germany accounted for 6.2% of the global vegan protein powder industry in 2022.

Competitive Landscape in the Vegan Protein Powder Market

Key players are actively expanding their product portfolios, focusing on research and development to improve taste and texture and investing in sustainable sourcing practices. They also employ innovative marketing strategies to reach a broader consumer base and capitalize on the growing demand for plant-based protein options. Additionally, these companies are forging strategic partnerships with retailers and health-conscious influencers to increase brand visibility and establish themselves as leaders in the rapidly growing vegan protein powder industry.

Recent Developments by Key Players

In June 2023, Synthite introduced two exciting new products to the Market. One of them is Just Plants, a plant-based dairy alternative, and the other is Protein, a plant-based protein drink powder.

In August 2021, Ascent, a rapidly growing sports nutrition company in the United States, unveiled a new range of organic plant-based protein powders to promote muscle health and enhance athletic performance.

Top Companies in Vegan Protein Power Market

  1. Archer Daniels Midland Company
  2. AGT Food and Ingredients
  3. Cargill Inc.
  4. A&B Ingredients
  5. Ingredion Incorporated

Vegan Protein Powder Market Segmentation

By Source:

  • Soy
  • Wheat
  • Pea
  • Others

By Flavors:

  • Unflavored
  • Chocolate
  • Vanilla
  • Strawberry
  • Blueberry
  • Others

By Application:

  • Food Processing
  • Nutritional Products
  • Animal Feed
  • Household (Retail)
  • Others

By Distribution Channel:

  • Direct Sales
  • Hypermarkets/Supermarkets
  • Specialty Stores
  • Pharmacy & Drug Stores
  • Online Stores
  • Others

By Regional Outlook:

  • North America (United States, Canada)
  • Latin America (Brazil, Mexico, Peru, Argentina, Chile, Rest of LATAM)
  • Europe (EU-4, United Kingdom, BENELUX, Nordics, Eastern Europe, Rest of Europe)
  • East Asia (China, Japan, South Korea)
  • South Asia & Oceania (India, Thailand, Indonesia, Malaysia, Australia, Rest of South Asia & Oceania)
  • Middle East & Africa (GCC Countries, Northern Africa, South Africa, Turkey, Rest of MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Herbs and Spices Market Insights: Exploring Regional Growth and Future Demand by 2034

Herbs and Spices Market
Herbs and Spices Market

The global herbs and spices market share is estimated to be US$ 171,563.1 million in 2024 increasing from US$ 167,874.1 million in 2019. FMI expects the global herbs and spices industry to grow at a 3.6% CAGR through 2033 to reach US$ 244,124.7 million by 2034.

The use of herbs and spices in convenient meals is growing because of their rich aroma taste and many health advantages., as consumers are now aware of the negative effects of artificial chemicals, they are gravitating toward foods and drinks that include real herbs and spices.

The sales of herbs and spices are being driven by the shifting preferences of consumers toward low-sugar food items and an increased curiosity about unique flavors. The need for herbs and spices has been fueled by a rise in the use of processed food items like sauces, dressings, and condiments.

The market is likely to witness considerable growth in sales of herbs and spices in the powder and granule form. The direct sales channel is expected to account for over 50% of the market share for herbs and spices, and it is anticipated to continue growing steadily during the forecast year.

Key Takeaways from the Herb and Spice Market Study Report

  • The herb and spice industry in the United States is anticipated to register the most lucrative CAGR of 5.9% through the forecast years.
  • In Europe, Germany is expected to witness the most promising CAGR of 4.2% in sales of herbs and spices through 2034.
  • Demand for herbs and spices is projected to increase at a rate of 4% per year till 2034 in China.
  • India is likely to hold the most lucrative market for herbs and spices in Asia thriving with a CAGR of 4.3% between 2024 and 2034.

Competitive Landscape for the Herb and Spice Market Players

The overall market is highly diversified and competitive owing to the presence of several market players at different levels. Key participants in the herbs and spices industry have extended their distribution networks, broadened their product offerings, and boosted production capacity as a result of acquiring small and medium-sized businesses.

“Quick-serve restaurants are anticipated to play a crucial role in the market growth of herbs and spices in the coming days. QSRs frequently employ dried herbs in their preparation and include sachets of dried herbs for customers to add to their dishes.” – says a lead analyst at FMI

Recent Developments by the Herb and Spice Industry Participants

In November 2022, Spice Story, an ethnic food company, expanded into the offline market by partnering with Jayanti Herbs and Spice. Spice Story was a direct-to-consumer business with 1200 physical storefronts with plans to open 15000 outlets by March 2023. The firm is expected to benefit from Jayanti Herbs & Spice’s 23,000-strong distribution network of contemporary, multi-brand retail locations, including national and regional chains.

In November 2022, Bart Ingredients introduced a variety of 19 herb and spice refill cartons into Morrisons. The cardboard boxes, which included items like smoked paprika, pink Himalayan salt, bay leaves, and black peppercorns, were delivered to 422 of the retailer’s locations. According to Bart Ingredients, these boxes are “92% lighter” than conventional glass jars and help to cut down on transportation-related emissions.

Key Players Profiled in the Herb and Spice Market Report

  • Givaudan S.A
  • Kerry Group Plc.
  • Ajinomoto Co., Inc.
  • Firmenich SA
  • Takasago International Corporation
  • Olam International
  • Archer Daniels Midland Company
  • Robertet SA
  • Sensient Technologies Corporation
  • Kalsec Inc.
  • McCormick & Company, Inc.
  • Symrise AG
  • Frutarom Industries Ltd
  • Synthite Industries Ltd
  • International Taste Solutions Ltd.

Key Segments Covered by Herb and Spice Industry Survey Report

By Product Type:

  • Herbs
  • Spices
  • Paprika (Hot Pepper)
  • Cumin

By End Use:

  • Food
    • Sauces, Dressings, and Condiments
    • Bakery and Confectionery
      • Bread/Cakes
      • Biscuits
      • Snacks
      • Candies
      • Other Baked Goods
    • Dairy Products
      • Flavored Milk
      • Cheese or Cheese Products
      • Butter Ice Creams
      • Other Dairy Products
    • Snacks & Savory Products
    • Processed Food
    • Soups
    • Flavored or Infused Oils
    • Other Foods
  • Beverage
  • Food Service
  • Retail Sales

By Form:

  • Powder & Granules
  • Flakes
  • Paste
  • Whole or Fresh

By Sales channel:

  • Direct Sales
  • Indirect Sales
    • Store-based Retailing
    • Online Retail

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia and Pacific
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Spice Oils and Oleoresins Market: Key Drivers and Future Forecast

Spice Oils and Oleoresins Market
Spice Oils and Oleoresins Market

According to Future Market Insights (FMI), the spice oils and oleoresins market may reach an overall valuation that is expected to surpass US$ 1,674.40 million in 2023. The market is expected to record a CAGR of 7.9% between 2023 and 2033. By 2033, the market is estimated to reach a valuation of US$ 3,567.2 million.

Significant Aspects Driving the Growth of the Market:

  • Oleoresins are used to create aromas, fragrances, and various cosmetic items. They are ideal for creating hair loss lotion, cologne, perfumes, and other cosmetics due to their consistency, texture, and fragrances.
  • They have multiple uses as they are considered anti-inflammatory, antioxidant, and used for treating cancer. Hence they are utilized in the pharmaceutical sector as a component of medications, medicinal soaps, and other products. Thus, these factors are expected to drive the growth of the market for cosmetics and medicines.
  • Analgesic properties of chili oleoresins help in the reduction of free radicals in the body thus making them useful in medicinal applications. Over the course of the projection period, the market is projected to be driven by all these important aspects.
  • The expanding consumption of organic foods and beverages has raised the need for organic spices, such as natural spice oils, oleoresins products, etc. The spice oils market and the oleoresins market are expected to experience significant growth in the coming years.
  • Sales of plant-based snacks, dips, spreads, sauces, creamers, cheese, and other foods and beverages are rising as consumers prefer the taste of spice oil as well as they are also interested in clean-label and vegan products. Thus, creating multiple prospects for the market.

Key Takeaways from Market Study

  • The spice oils and oleoresins market is expected to reach an overall valuation of US$ 1,674.40 million in 2023.
  • The spice oil and oleoresin market in Germany is expected to record a CAGR of 7%
  • The spice oil and oleoresin market in China is expected to reach a valuation of US$ 567.18 million by 2033. The market is expected to record a CAGR of 7% over the forecast period.
  • The spice oil and oleoresin market in Spain is expected to record a CAGR of 5.4%

Competitive Landscape:

Companies look for inorganic growth strategies, such as alliances, global expansion, and mergers and acquisitions, in order to maintain a competitive position in the market. Major players in the global spice oil and oleoresin market are concentrating on launching cutting-edge goods that meet the needs of consumers in order to increase their operational presence in various regions of the world.

Some of the Key Players in the Spice Oil and Oleoresin are:

  • Young Living Essential Oils Ltd.
  • Reckitt Benckiser Group Plc (RB)
  • Symrise AG
  • Givaduan AG
  • Greenleaf Extractions Pvt. Ltd.
  • Indian Spice Oil Industries
  • Synthite Industries Ltd.
  • Universal Oleoresins Pvt. Ltd.

Recent Developments:

  • The well-known Dutch oil company Ultra International B.V. operates in important regions and has offices in Singapore, the United States, Australia, India, and the Middle East. The company uses medicinal plants including eucalyptus, coriander, cumin, and cloves to create various kinds of oils.
  • A well-known producer of essential oils, DoTERRA International LLC, entered the South American market in September 2019. The company produced therapeutic essential oils using oleoresin. This innovation has made the best medicinal oils that are easily accessible to customers in South America.

Key Segments

Product Type:

  • Spice Oils
  • Oleoresins

Distribution Channel:

  • B2B/Direct
  • B2C/Indirect

Nature:

  • Organic
  • Conventional

Application:

  • Food & Beverages
  • Bakery & Confectionery
  • Beverages
  • Dressings & Condiments
  • Sauces, Spreads & Soups
  • Cosmetics and Personal Care
  • Skin Care
  • Hair Care
  • Toiletries.
  • Aromatherapy
  • Pharmaceuticals
  • Household
  • Dietary Supplements
  • Foodservice
  • Industrial

Region:

  • North America (United States & Canada)
  • Latin America (Mexico, Brazil, Peru, Argentina & Rest of Latin America)
  • Europe (EU-4, BENELUX, Nordic Countries, Russia, Poland & Rest of Europe)
  • South Asia (India, Thailand, Indonesia, Malaysia, and Rest of South Asia)
  • East Asia (China, Japan & South Korea)
  • Oceania (Australia & New Zealand)
  • Middle East & Africa (GCC, Northern Africa, South Africa & Rest of MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Yellow Pea Protein Market Analysis: Growth Trajectory and Trends Through 2033

Yellow Pea Protein Market

The yellow pea protein market is predicted to capture a valuation of USD 3.3 billion in 2023 and is projected to rise to USD 11.5 billion by 2033. As per the FMI report, the market is likely to register a CAGR of 14.4% during the forecast period.

Food & beverage manufacturers are developing nutrition supplements by increasing the adoption of yellow pea protein, such as energy drinks and smoothies. The rising consumer demand for vegan, high-fiber, clean-label, and non-toxic food products is surging market growth. In addition, growing awareness related to health and rising cardiovascular diseases is rapidly increasing yellow pea protein nutrition.

Increasing disposable income, urbanization, population, and changing eating habits fuel market opportunities. Manufacturers are developing food & beverage products by adopting advanced technology and adding natural ingredients. In addition to that, it enhanced the shelf-life of food and improved quality by adding vegan ingredients surging the product demand globally. Growing consumer demand for food items such as plant-based milk, vegan burger, milkshakes, and supplements drive the yellow pea protein market.

Social media influencers, athletes, and famous personalities promote top companies’ brands to make people aware customers of healthy diets. The yellow pea protein is the better alternative source that reduces weight and cholesterol and promotes a healthy heart. However, people cannot maintain their healthy lifestyles due to hectic lifestyles. Therefore, plant-based protein producers develop packed supplements to provide proper healthy nutrition to their consumers.

High Cost of Yellow Pea Protein Limits the Market Growth

The market is promoting a healthy lifestyle by increasing the production of plant-based products. However, key manufacturers faced certain roadblocks that declined the market growth, which included the increasing cost of yellow pea protein supplements and Isolates restraining the market growth.

The low availability of plant-based raw materials and alternate substitutes limits the market growth. Moreover, a few consumers suffer from lactose intolerance hinders the market.

Key Takeaways:

  • The yellow pea protein market is expected to have a valuation of US$ 11.5 billion by 2033.
  • With a CAGR of 14.4%, the global market is increasing during the forecast period.
  • The market in the United States is anticipated to capture a CAGR of 8.9% through 2033.
  • With a CAGR of 11.6%, the United Kingdom yellow pea protein market significantly uplifts during the forecast period.
  • German market is expected to secure a CAGR of 9.8% over the forecast period.
  • China market is capturing a CAGR of 13.2% by 2033.

Who is Winning?

The key players play a vital role in the global market by capturing maximum revenue by investing their amount in research and development activities. In addition, these players are focusing on developing better quality products per consumers’ requirements.

The prominent players innovate plant-based products to promote a healthy lifestyle by adopting several marketing methodologies. Marketing strategies adopted by these players are collaborations, mergers, partnerships, product launches, and acquisitions.

Other Prominent Players in the Market are:

  • Cargill Inc.
  • DuPont de Nemours, Inc.
  • The Scoular Company
  • Axiom Foods, Inc.
  • Glanbia Ple
  • Roquette Frères
  • Kerry Group PLC
  • Bata Food
  • Shandong ianyan Group
  • The Green Lab LLC
  • Puris Proteins LLC
  • Burcon NutraScience Corporation
  • Cosucra Groupe Warcoing S.A.

Recent Developments in the Market are:

  • In 2018, Axiom Foods announced its new distributor Univar Solutions, to supply goods & services of plant-based ingredients.
  • In 2021, Puris Proteins LLC announced a newly launched plant for manufacturing yellow pea protein to upsurge its business in the United States.
  • In February 2018, DuPont de Nemours Inc announced its launch of BAIC (Bay Area Innovation Center) to upsurge agricultural biotechnology and technological development.

Yellow Pea Protein Market by Category

By Product Type:

  • Protein Concentrates
  • Protein Isolates
  • Textured Protein
  • Hydrolyzed Protein

Processing Type:

  • Dry Processing
  • Wet Processing

End Use:

  • Food Processing
  • Meat Alternatives
  • Bakery Products
  • Confectionery
  • Snacks & Cereals
  • Meat-based Products
  • Functional Beverages
  • Others
  • Animal Feed
  • Nutraceuticals
  • Sports Nutrition
  • Infant Nutrition
  • Cosmetic & Personal Care

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Migraine Treatment Market Poised for Robust Growth, Projected to Reach USD 4.74 Billion by 2033

The global migraine treatment market is set to witness significant expansion, with projections estimating a market value of USD 3.2 billion in 2023, climbing to an impressive USD 4.74 billion by 2033. This growth trajectory reflects a Compound Annual Growth Rate (CAGR) of 4% over the forecast period of 2023 to 2033. Historically, the market demonstrated a steady CAGR of 3% from 2018 to 2022.

Meeting the Growing Demand for Migraine Management:

The Migraine Treatment market represents a crucial segment of the healthcare industry, addressing a condition that affects millions globally. The market encompasses a diverse portfolio of products and services aimed at managing migraine symptoms effectively. Key offerings include:

  • Medications: Over-the-counter pain relievers such as aspirin and ibuprofen.
  • Lifestyle Modifications: Strategies like maintaining a consistent sleep schedule, avoiding triggers, and engaging in stress-relief activities like exercise or meditation.
  • Advanced Therapies: Neuromodulation devices, cognitive-behavioral therapy (CBT), acupuncture, and nutritional supplements.

This comprehensive approach underscores the industry’s commitment to improving patient quality of life and managing the complexities of migraine treatment.

Drivers of Market Growth:

Several factors contribute to the positive outlook for the Migraine Treatment market:

  1. Increasing Prevalence: Rising awareness of migraine and its management options has led to higher diagnosis rates, driving market demand.
  2. Technological Advancements: Innovations in neuromodulation devices and non-invasive therapies are broadening treatment options.
  3. Lifestyle Awareness: Growing emphasis on holistic health, including stress management and nutrition, complements traditional medication.

Enhanced Market Demand! Discover Thorough Trends and Insights in Our Complete Report!

Future Outlook:

As the burden of migraines continues to impact individuals and healthcare systems worldwide, the demand for effective and innovative treatment solutions will only grow. Market stakeholders are focusing on R&D investments to develop advanced therapies, ensuring enhanced efficacy and patient compliance.

With steady growth and evolving treatment modalities, the Migraine Treatment market stands as a vital contributor to the healthcare industry, poised to make a lasting impact on millions of lives.

Key Takeaways from the Market Study:

  • From 2018 to 2022, the migraine treatments market grew at a CAGR of 3%.
  • The global migraine treatments market is expected to grow with a 4% CAGR during 2023 to 2033.
  • As of 2033, the migraine treatments Market is expected to reach USD 4.74 Billion.
  • According to the FMI analysis, hospitals account for the largest market share.
  • North America is expected to possess 40% market share for the migraine treatments market.
  • The East & South Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering migraine treatments.” says an FMI analyst

Market Competition:

Key players in the market include companies such as Voyager Therapeutics, Spark Therapeutics, Novartis AG, Bluebird bio, Inc., Biogen, Pfizer Inc., Rapa Therapeutics, BrainStorm Cell Therapeutics, Eli Lilly and Company, and UniQure Biopharma, along with healthcare providers and technology companies among other global players.

  • In November 2022, A team of researchers at University College London (UCL) developed a novel gene therapy that offers promise in treating neurological and psychiatric disorders. The therapy targets overactive brain cells that are responsible for causing several brain diseases, including epilepsy, by reducing their excitability. By using DNA sequences that control gene expression, the therapy drives the production of molecules that prevent these overactive cells from firing, thereby curbing epileptic seizures. Notably, the technique selectively alters only overactive cells while sparing normally functioning cells.
  • In preclinical studies, the new treatment demonstrated a higher efficacy than previous gene therapies or anti-seizure drugs tested in the same model. The team observed an approximately 80% reduction in spontaneous seizures in epileptic mice treated with the therapy. Furthermore, the researchers believe that this gene therapy has the potential to treat other disorders where some brain cells are overactive, such as Parkinson’s disease.

Key Segments Profiled in the Migraine Treatment Industry Survey:

Drug Class:

  • Zavegepant
  • Atogepant
  • Zolmitriptan

Route of Administration:

  • Oral
  • Parenteral
  • Nasal Sprays

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Treatment:

  • Abortive Medicine
  • Preventive Medicine

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Hepatic Encephalopathy Treatment Market on a Robust Growth Trajectory: Expected to Reach USD 2971.51 Million by 2033

The global hepatic encephalopathy treatment market is set to achieve significant growth, with projections indicating an increase from USD 1583 Million in 2023 to USD 2971.51 Million by 2033, reflecting a CAGR of 6.5% during the forecast period. The market witnessed a moderate growth rate of 3.9% CAGR during the historical period of 2018 to 2022, which is now accelerating due to a surge in liver-related disorders worldwide.

Key Market Drivers:

The rise in liver diseases, including cirrhosis and non-alcoholic fatty liver disease (NAFLD), is a primary factor fueling market growth. As hepatic encephalopathy stems from the liver’s inability to eliminate toxins from the bloodstream effectively, leading to toxin buildup in the brain, the demand for comprehensive treatment solutions continues to grow.

Understanding Hepatic Encephalopathy:

Hepatic encephalopathy is a severe condition that can range from mild to life-threatening, characterized by symptoms such as:

  • Cognitive dysfunction: Confusion and personality changes.
  • Neurological issues: Tremors and loss of motor control.
  • Severe outcomes: Potential progression to coma in advanced stages.

Effective management of HE involves addressing its root causes, primarily liver diseases like cirrhosis. Treatments include:

  • Medication: To reduce toxin levels in the bloodstream.
  • Dietary modifications: Tailored to support liver health.
  • Lifestyle changes: Including alcohol cessation and regular medical monitoring.

Future Outlook:

With advancements in medical research and increased awareness, the HE treatment market is poised for steady growth. Pharmaceutical innovations and comprehensive management strategies targeting liver health will play a critical role in shaping the market landscape.

As the prevalence of liver disorders continues to rise, so does the importance of effective hepatic encephalopathy treatments. The robust growth projected for the global HE treatment market underscores the urgency and potential for innovation in managing this critical condition, paving the way for improved patient outcomes and a healthier global population.

Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!

Key Takeaways from the Market Study:

  • The Hepatic encephalopathy treatment market is expected to grow at a value of 6.5% CAGR in the forecast period 2023-2033
  • Hospital pharmacies are expected to hold 49% of the market share in 2023 for Hepatic encephalopathy treatment market.
  • North America is expected to possess 44% market share for Hepatic encephalopathy treatment market in 2023.
  • Asia Pacific Hepatic encephalopathy treatment market size is expected to possess 39% market share in 2023.

“The Hepatic Encephalopathy Treatment Market is also being driven by the increasing adoption of combination therapies for HE.” states an FMI analyst

Competitive Landscape:

Key players in the hepatic encephalopathy treatment market are Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline plc., Pfizer Inc., ASKA Pharmaceutical Co., Ltd., Bausch Health, Johnson & Johnson Services, Inc., Janssen Global Services, Takeda Pharmaceutical Company Limited, Merck & Co., Inc.

  • Mallinckrodt Pharmaceuticals has developed and marketed several medications for the treatment of Hepatic Encephalopathy that include Ofirmev and Terlipressin (Glypressin) injection. In addition to these medications, Mallinckrodt Pharmaceuticals has also sponsored clinical research into the treatment of HE, with a focus on developing new treatments and improving the understanding of the condition.
  • Salix Pharmaceuticals has developed Xifaxan (rifaximin) tablets. Xifaxan is an antibiotic medication that works by reducing the levels of bacteria in the gut, which can help reduce the production of toxins that contribute to the development of HE.

Key Segments Profiled in the Hepatic Encephalopathy Treatment Industry Survey

Drug Class:

  • Antibiotics
  • Laxatives
  • L-ornithine
  • L-aspartate

Diagnosis:

  • Blood Tests
  • CT Scan
  • Liver Functioning Tests

Route of Administration:

  • Oral
  • Injectable
  • Intravenous
  • Others

Distribution Channel:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global GLP-1 Receptor Agonist Market Set for Exceptional Growth: Projected to Surge USD 72,127.79 Million by 2034 grow at a CAGR of 11.7%

The global GLP-1 receptor agonist market is poised for extraordinary expansion, driven by an increase in therapeutic applications and favorable market projections. Recent analysis indicates a promising trajectory, with expectations for the market to grow from USD 23,854.53 million in 2024 to an impressive USD 72,127.79 million by 2034. This meteoric rise reflects a robust Compound Annual Growth Rate (CAGR) of 11.7%, establishing the market as a dynamic and high-growth sector within the pharmaceutical industry.

GLP-1 receptor agonists are essential in managing type 2 diabetes and various metabolic disorders. Their growing effectiveness in glycemic control and weight management is garnering significant attention, and expanding therapeutic applications are further propelling market growth. This expansion is supported by ongoing research and development efforts that are advancing these life-changing therapies.

Key Drivers of Market Growth:

  1. Increased Prevalence of Type 2 Diabetes: The rising global incidence of type 2 diabetes is a major catalyst for demand for effective management solutions, notably GLP-1 receptor agonists.
  2. Advancements in Drug Formulations: Continuous innovations in drug delivery systems and formulations are enhancing the therapeutic profiles of GLP-1 receptor agonists, broadening their clinical applications.
  3. Growing Patient Awareness and Accessibility: Increased awareness among patients and improved access to healthcare services are facilitating the greater adoption of GLP-1 receptor agonists across diverse demographics.
  4. Supportive Regulatory Environment: Favorable regulatory policies and expedited approval processes are creating a conducive environment for the development and commercialization of new GLP-1 receptor agonist therapies.

The projected growth trajectory of the GLP-1 receptor agonist market underscores its potential to address unmet medical needs and transform patient outcomes. Stakeholders across the industry, including pharmaceutical companies, healthcare providers, and investors, stand to benefit from this dynamic expansion and the evolving opportunities it presents.

Key Takeaways from the Market Study:

  • Type-2 Diabetes dominates the GLP-1 receptor agonist market by indication, accounting for a share of 75.00%.
  • Hospital pharmacies lead the distribution channel in the GLP-1 receptor agonist industry, accounting for a 34.00 % market share.
  • The GLP-1 receptor agonist market in India has the potential to increase at 24.70% CAGR through 2034.
  • The market in China is anticipated to develop at a CAGR of 23.10 % through 2034.
  • The market in the United Kingdom is predicted to rise at a CAGR of 12.10% through 2034.

Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report!

Competitive Landscape:

Pharmaceutical companies use various strategies for market expansion. These include conducting clinical trials to broaden the indications for existing products and targeting additional disease areas such as obesity and NAFLD. They are also developing innovative formulations and delivery systems to improve patient convenience and adherence.

Companies are investing in marketing and educational initiatives to raise awareness among healthcare professionals and patients about the benefits of GLP-1 receptor agonists in diabetes management.

Recent Developments:

  • Eli Lilly introduced Orforglipron in June 2023, which could revolutionize treatment options for obesity and type 2 diabetes.
  • In October 2023, researchers created chimeric GLP-1 receptor agonists that show promise as long-lasting treatments for type 2 diabetes.
  • In November 2023, researchers developed a groundbreaking long-acting GLP-1 agonist that could offer promising advancements in diabetes management.
  • In August 2023, GLP-1 medications like Ozempic, Wegovy, and Mounjaro reshaped the pharmaceutical landscape by curbing appetites and triggering significant weight loss.

Key Companies in the Market:

  • Eli Lilly and Company
  • Sanofi
  • Novo-Nordisk A/S
  • AstraZeneca
  • Pfizer.Inc
  • Amgen, Inc.
  • Innovent Biologics, Inc.
  • PegBio Co., Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH

Key Market Segmentation:

By Drug Class:

  • Exenatide
  • Liraglutide
  • Dulaglutide
  • Lixisenatide
  • Others

By Route of Administration:

  • Parenteral
  • Oral

By Indication:

  • Diabetes
  • Cardiovascular Disease
  • Weight Management
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Clinics
  • Ambulatory Surgical Centres

By Region:

  • Asia Pacific
  • Europe
  • North America
  • Middle East & Africa
  • Latin America

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Artificial Tears Market Poised for Remarkable Growth, Expected to Reach USD 5.8 Billion by 2034 expand at a CAGR of 5.4%

The global artificial tears market is set to experience robust growth in the coming years, with a projected valuation of USD 3.4 billion in 2024, expanding at a compound annual growth rate (CAGR) of 5.4% to reach an impressive USD 5.8 billion by 2034, according to a recent report by Future Market Insights.

The healthcare industry is experiencing significant changes to develop a robust system to improve eye care.  Nanomicellular technology is a strong system used in artificial tears production. These are utilized as pharmaceutical carriers for dissolving hydrophobic medications.

Substances like povidone simulate mucin’s function, tears’ adhesion to the ocular surface, and the component of the inner tear. Due to prolonged exposure to blue light emitted from digital screens, higher use of mobile phones, rising pollution levels, and dry weather spells, there has been a significant increase in dry eye symptoms among persons in their teens and 20s during the past five years.

“Increasing strategic activities among key players and rising focus toward developing new artificial tears are expected to witness an advancement over the forecast period.”, says an analyst of FMI.

Key Takeaways from the Market Study:

  • Glycerine tears are the leading segment of artificial tears and will hold around 4% market value share in 2024; glycerine eyes reduce the burning, itching, and feeling that something is in the eyes associated with dry eyes.
  • The solution is set to lead in terms of the dosage form of artificial tears with a projected market value share of around 2% by 2034.
  • By formulation, non-preservative-based is leading in the global artificial tears market and is expected to continue to do so with a projected CAGR of 6% during the forecasted years with a market share of 55.2% in the year 2024.
  • Dry eye syndrome holds a substantial share of 2% in the artificial tears market, with a CAGR of 5.4% during the forecast period. Dry eye syndrome is a multifactorial ocular surface disease brought on by a breakdown in the tear film’s equilibrium.
  • Retail pharmacies as a distribution channel are leading in the global artificial tears market. They are expected to continue to do so with a projected CAGR rate of 6% during the forecast years, with a market share of 38.0% in 2024.
  • North America is the leading region with a value share of 9% in 2024, owing to the high prevalence of ocular problems such as eye allergies.

Expanding Market Need: Access Our Full Report for In-Depth Analysis and Trends!

Market Competition:

The market for artificial tears is fragmented, and several local, upcoming, and established players exist within the market. Key players have initiated marketing initiatives to educate the elderly population about the benefits of artificial tears while also attempting to improve the drugs with different specifications.

  • On 7 October 2019, Allergan plc announced three new over-the-counter (OTC) products: REFRESH RELIEVA, REFRESH RELIEVA PF (preservative-free) multidose, and REFRESH RELIEVA, respectively. This new line of artificial tear formulations is intended for contact lens wearers and was developed to reduce discomfort caused by eye dryness and to stop irritation.
  • On 5 November 2022, I-MED Pharma announced the launch of an innovative dry eye product portfolio in the United States. A company that offers a wide range of products, such as I-DROP artificial tears and I-LID ‘N LASH ocular hygiene cleaners.

Key Players in the Artificial Tears Market:

  • AbbVie, Inc.
  • Akorn, Inc.
  • Alcon
  • Bausch & Lomb
  • Johnson & Johnson
  • Eyevance Pharmaceuticals LLC
  • Ocusoft
  • I- MED PHARMA
  • Santen Pharmaceutical Co. Ltd
  • Similasan Corporation
  • Sun Pharmaceutical Industries Ltd
  • Ursapharm Arzneimittel GmbH
  • Novartis International AG
  • AFT Pharmaceuticals

Key Segments Covered in Artificial Tears Market:

By Product Type:

  • Glycerine Tears
  • Cellulose Tears
  • Oil-based Emulsion Tears
  • Polyethylene Glycol-based Tears
  • Sodium Hyaluronate Based Artificial Tears
  • Propylene Glycol-based Tears

By Dosage Form:

  • Solution
  • Ointment
  • Emulsion
  • Gel
  • Spray
  • Suspensions

By Formulation:

  • Preservative Based
  • Non-Preservative Based

By Indication:

  • Dry Eye Syndrome
  • Allergies
  • Infections
  • UV & Blue Light Protection
  • Contact Lens Moisture Retention
  • Others

By Distribution channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Ophthalmic Stores

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube